Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Ascierto and Luigi Atripaldi.
Paolo Ascierto
Connection Strength
0.925
Luigi Atripaldi
  1. Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-a Expression. Biology (Basel). 2021 Aug 01; 10(8).
    View in: PubMed
    Score: 0.240
  2. Could asymptomatic carriers spread the SARS-CoV-2 infection? Experience from the Italian second wave. J Transl Med. 2021 03 02; 19(1):93.
    View in: PubMed
    Score: 0.233
  3. Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J Immunother Cancer. 2020 08; 8(2).
    View in: PubMed
    Score: 0.224
  4. Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based study. Future Sci OA. 2021 Jan 12; 7(4):FSO673.
    View in: PubMed
    Score: 0.058
  5. Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection. J Transl Med. 2020 12 21; 18(1):488.
    View in: PubMed
    Score: 0.057
  6. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 10 21; 18(1):405.
    View in: PubMed
    Score: 0.057
  7. TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol. Contemp Clin Trials. 2020 11; 98:106165.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.